NASDAQ:PCRX - Nasdaq - US6951271005 - Common Stock
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 862.07M | 674.98M | 666.80M | 541.50M | 429.60M | |||
Cost Of Goods | 225.65M | 184.67M | 199.30M | 140.30M | 117.30M | |||
Gross Profit | 636.42M | 490.31M | 467.50M | 401.30M | 312.30M | |||
Operating Expenses | 519.30M | 402.99M | 396.60M | 268.40M | 251.90M | |||
Research and Development | 95.38M | 76.26M | 84.80M | 55.50M | 59.40M | |||
Selling, General, and Administrative Expenses | 352.31M | 269.44M | 254.50M | 199.30M | 184.50M | |||
Operating Income | 117.12M | 87.32M | 70.90M | 132.80M | 60.50M | |||
Interest Income/Expense | 2.87M | -8.86M | -35.40M | -30.90M | -21.00M | |||
Other Income/Expense | 36.00K | -186.00K | -11.30M | -2.70M | 2.90M | |||
Non Recurring Items | -161.30M | -16.57M | -10.90M | -42.90M | -22.20M | |||
Income Before Taxes | -41.27M | 61.70M | 13.30M | 56.40M | 20.10M | |||
Income Tax | 40.48M | 19.75M | -2.60M | 14.40M | -125.40M | |||
Net Income | -81.75M | 41.95M | 15.90M | 42.00M | 145.50M | |||
EBITDA | 193.14M | 162.90M | 162.40M | 161.30M | 80.40M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.95 | 0.80 | 0.34 | 0.92 | 3.33 | |||
Non GAAP EPS | 3.19 | 2.92 | 2.59 | 2.99 | 2.20 | |||
Statistics | ||||||||
Gross Profit Margin | 73.82% | 72.64% | 70.11% | 74.11% | 72.70% | |||
Profit Margin | -9.48% | 6.22% | 2.38% | 7.76% | 33.87% | |||
Operating Profit Margin | 13.59% | 12.94% | 10.63% | 24.52% | 14.08% |
All data in USD